Dawn Alderman, AxioMx Inc. Interview: Eliminating Bottlenecks in Antibody Development with Alpha Technology

4,697 views

|

August 22, 2013

Watch this video interview to hear Dawn Alderman describe how AxioMx Inc. is using AlphaScreen® no-wash assay technology in multiple stages of the antibody development pipeline, including primary detection, QC and KD determination. She explains how the implementation of AlphaScreen has eliminated throughput bottlenecks and simplified procedures. Find out more about Alpha technology at: www.perkinelmer.com/AlphaTech

BiopharmaBioprocessingCell ScienceImmunology

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.